We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04373460
Recruitment Status : Active, not recruiting
First Posted : May 4, 2020
Last Update Posted : June 7, 2022
Sponsor:
Collaborators:
State of Maryland
Bloomberg Foundation
United States Department of Defense
National Institute of Allergy and Infectious Diseases (NIAID)
National Center for Advancing Translational Sciences (NCATS)
Information provided by (Responsible Party):
Johns Hopkins University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : January 14, 2022
Estimated Study Completion Date : September 14, 2022
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):